#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anal fistula Immune-mediated renal disorder Extraskeletal ossification Ureteric cancer Thermal burn Cardiac amyloidosis Hereditary spastic paraplegia Synovitis Cholangiocarcinoma Haemophilia B with anti factor IX Atopic keratoconjunctivitis Chronic lymphocytic leukaemia recurrent Short stature homeobox gene mutation Frostbite Arterial tortuosity syndrome More trials…

    Learn about Rare Diseases

    Alagille syndrome – Basic Information Hepatic angiosarcoma – Trials in Disease Leukoencephalopathy – Treatment Epidermolysis bullosa – Basic Information Alternating hemiplegia of childhood – Trials in Disease Usher’s syndrome – Trials in Disease Mantle cell lymphoma stage II – Life with Disease Medulloblastoma – Diagnostics Von Willebrand’s disease – Trials in Disease Lymphangiosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Berotralstat IMELASOMERAN Cortisone Meglumine Gadoterate Eftilagimod Alfa Phleum Pratense (225) Permethrin Stro-002 Naloxegol Oxalate Gns561 Ly3484356 Magnesium Oxide, Light KETOROLAC TROMETAMOL Egl-001 Capmatinib Vismodegib Viltolarsen Sonelokimab Daunorubicin Ibuprofen Lysine More therapies…

    Learn about Your Condition

    Schizoaffective disorder Erythema migrans Malignant peritoneal neoplasm Colorectal adenoma Juvenile idiopathic arthritis Prostatitis Escherichia coli Hyperinsulinism Peripheral ischaemia Acute respiratory failure Nocturia MELAS syndrome Femur fracture Pustular psoriasis Premature baby Essential thrombocythaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on CAR-T-cell Therapy with Rituximab and Ibrutinib for Patients with High-Risk Mantle Cell Lymphoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Brexucabtagene Autoleucel
    • Bendamustine
    • Melphalan
    Czechia France Germany The Netherlands Spain

  • Study on Early Oral Antibiotic Treatment for Vertebral Osteomyelitis Using Cefuroxime, Dicloxacillin, and Ceftriaxone for Adult Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteomyelitis
    Investigated Drugs:
    • Benzylpenicillin
    • Dicloxacillin
    • Moxifloxacin
    Denmark

  • Study on Sotatercept for Children with Pulmonary Arterial Hypertension Receiving Standard Care

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Sotatercept
    France Germany The Netherlands Poland Spain

  • Study of Intranasal Sufentanil and Intravenous Morphine for Severe Sickle Cell Pain Crisis in Children

    Recruiting

    3 1 1
    Investigated Diseases:
    • Sickle cell anaemia with crisis
    Investigated Drugs:
    • Sufentanil
    • Morphine Hydrochloride
    • Sodium Chloride
    France

  • Study on Optimizing CDK 4/6 Inhibitors and Endocrine Therapy for Older Patients with Advanced Breast Cancer Using Abemaciclib, Palbociclib, and Ribociclib

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer
    Investigated Drugs:
    • Anastrozole
    • Exemestane
    • Palbociclib
    Finland Greece Italy Norway Spain Sweden

  • Study on Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan for Adults with Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Lutetium (177Lu) Vipivotide Tetraxetan
    Austria Belgium Czechia France Germany Italy +4
Previous Page
1 … 553 554 555 556 557 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!